Construction and Validation of a Novel Prognosis Model in Colon Cancer Based on Cuproptosis-Related Long Non-Coding RNAs
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Construction and Validation of a Novel Prognosis Model in Colon Cancer Based on Cuproptosis-Related Long Non-Coding RNAs
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 12, Issue 4, Pages 1528
Publisher
MDPI AG
Online
2023-02-15
DOI
10.3390/jcm12041528
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma
- (2023) Duguang Li et al. Frontiers in Immunology
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer
- (2022) Zhiwei Wu et al. Frontiers in Immunology
- LncRNA PVT1 is increased in renal cell carcinoma and affects viability and migration in vitro
- (2022) Julia Bohosova et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Copper induces cell death by targeting lipoylated TCA cycle proteins
- (2022) Peter Tsvetkov et al. SCIENCE
- Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer
- (2022) Jinhui Liu et al. Frontiers in Cell and Developmental Biology
- Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma
- (2022) Hongjun Xie et al. Frontiers in Immunology
- Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer
- (2022) Yaobin Lin et al. BMC Medical Genomics
- m6A-Related Angiogenic Genes to Construct Prognostic Signature, Reveal Immune and Oxidative Stress Landscape, and Screen Drugs in Hepatocellular Carcinoma
- (2022) Xiaodong Qu et al. Oxidative Medicine and Cellular Longevity
- Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma
- (2022) Zhuning Wang et al. Journal of Immunology Research
- A novel cell senescence-related IncRNA survival model associated with the tumor immune environment in colorectal cancer
- (2022) Chengfei Xu et al. Frontiers in Immunology
- Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
- (2022) Xin Yang et al. Clinical Epigenetics
- Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
- (2022) Zhixun Bai et al. Biomolecules
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Diagnosis and Treatment of Metastatic Colorectal Cancer
- (2021) Leah H. Biller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer
- (2021) Zhangjian Zhou et al. Frontiers in Genetics
- Dysregulations of long non-coding RNAs − The emerging “lnc” in environmental carcinogenesis
- (2021) Po-Shun Wang et al. SEMINARS IN CANCER BIOLOGY
- LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers
- (2021) Junbo Xiao et al. Frontiers in Molecular Biosciences
- Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma
- (2021) Zi-An Chen et al. Frontiers in Oncology
- Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma
- (2021) Gaoteng Lin et al. Frontiers in Molecular Biosciences
- Deciphering the Pyroptosis-Related Prognostic Signature and Immune Cell Infiltration Characteristics of Colon Cancer
- (2021) Ran Wei et al. Frontiers in Genetics
- Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma
- (2021) Ziyuan Ren et al. Frontiers in Cell and Developmental Biology
- Colorectal cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global Burden of 5 Major Types Of Gastrointestinal Cancer
- (2020) Melina Arnold et al. GASTROENTEROLOGY
- A Nuclear Long Non-Coding RNA LINC00618 Accelerates Ferroptosis in a Manner Dependent upon Apoptosis
- (2020) Zuli Wang et al. MOLECULAR THERAPY
- Choosing tumor mutational burden wisely for immunotherapy: A hard road to explore
- (2020) Rui Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Long noncoding RNAs: functions and mechanisms in colon cancer
- (2020) Sian Chen et al. Molecular Cancer
- The molecular machinery of regulated cell death
- (2019) Daolin Tang et al. CELL RESEARCH
- Cancer treatment and survivorship statistics, 2019
- (2019) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients
- (2019) Michael J. Duffy et al. CLINICAL CHEMISTRY
- High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients
- (2019) Dedong Cao et al. OncoImmunology
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
- (2019) Jeanne Tie et al. JAMA Oncology
- A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53
- (2018) Chao Mao et al. CANCER RESEARCH
- Clinical utility of circulating non-coding RNAs — an update
- (2018) Simone Anfossi et al. Nature Reviews Clinical Oncology
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- Defining the human copper proteome and analysis of its expression variation in cancers
- (2017) S. Blockhuys et al. Metallomics
- LncRNA-mediated regulation of cell signaling in cancer
- (2017) W-X Peng et al. ONCOGENE
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression
- (2016) Belinda Phipson et al. Annals of Applied Statistics
- Use of Tumor Markers in Gastrointestinal Cancers: Surgeon Perceptions and Cost-Benefit Trade-Off Analysis
- (2016) Amish Acharya et al. ANNALS OF SURGICAL ONCOLOGY
- Effect of diagnostic delay on survival in patients with colorectal cancer: a retrospective cohort study
- (2016) Salvador Pita-Fernández et al. BMC CANCER
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers
- (2015) Xiaohui Yan et al. CANCER CELL
- Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients
- (2015) Rodrigo Dienstmann et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Successes, toxicities and challenges in solid tumours
- (2014) Joel W. Neal et al. Nature Reviews Clinical Oncology
- pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
- (2014) Paul Geeleher et al. PLoS One
- Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma
- (2013) Marc Tänzer et al. PHARMACOLOGY & THERAPEUTICS
- Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks
- (2013) Paul Blanche et al. STATISTICS IN MEDICINE
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring
- (2012) Thomas A. Gerds et al. STATISTICS IN MEDICINE
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Curable Metastatic Colorectal Cancer
- (2011) Matthew J. Eadens et al. Current Oncology Reports
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started